Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

Clinical trial NCT03397914 · COMPLETED

Trial details

NCT number: NCT03397914
Sponsor: National Cancer Institute, Egypt
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gram-Negative Bacterial Infections Pediatric Cancer Colistin Colistin Adverse Reaction MIC

Start date: 2017-01-01
Primary completion: 2019-01-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.